Latest Breaking News On - Aligos therapeutics inc - Page 8 : comparemela.com

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

November 16 Event to feature KOL perspective on Emerging HBV TherapiesSOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on.

United statesTemple universityCorey davisVeronica eamesMark sulkowskiExchange commission onDepartment of medicineJohns hopkins university school of medicineTemple university school of medicineAmerican association of liver disease onAmerican society for clinical investigationLifesci communicationsInfectious diseases society of americaViral hepatitis centerMedicine at duke university school ofClinical trials group

Aligos Therapeutics, Inc (ALGS) Tops Q3 EPS by 7c

Aligos Therapeutics, Inc (ALGS) Tops Q3 EPS by 7c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aligos therapeutics incAligos therapeutics

Aligos Therapeutics Inc (ALGS) Reports Q3 2023 Financial Results and Business Progress

Company raises $92 million in private placement financing and secures $8.5 million contract with NIAID

Aligos therapeutics incTherapeutics incCash equivalentsIopharmaceutical companyPrivate placementE3 2022E3 2023

Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023

Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Corey davisVeronica eamesLifesci communicationsExchange commission onAligos therapeutics incExchange commissionQuarter resultsSecurities litigation reform actAligo quarterly report

Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023

Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesCorey davisVeronica eamesAligos therapeutics incExchange commissionUniversity of hong kongLifesci communicationsExchange commission onTherapeutics to present late breaking posterLiver meetingAmerican associationLiver diseasesSecurities litigation reform actAligo quarterly report